IRIS
VESPASIANI GENTILUCCI, UMBERTO
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
AS - Asia 9.130
NA - Nord America 1.645
EU - Europa 718
SA - Sud America 461
AF - Africa 48
OC - Oceania 25
Totale 12.027
Salva come PNG Salva come JPEG
Nazione #
SG - Singapore 7.091
US - Stati Uniti d'America 1.564
CN - Cina 928
HK - Hong Kong 681
BR - Brasile 339
VN - Vietnam 232
GB - Regno Unito 192
IT - Italia 175
DE - Germania 112
IN - India 54
CA - Canada 47
AR - Argentina 46
FI - Finlandia 42
NL - Olanda 35
ID - Indonesia 30
CZ - Repubblica Ceca 28
EC - Ecuador 28
AU - Australia 24
MX - Messico 24
PL - Polonia 23
TR - Turchia 23
UA - Ucraina 22
ZA - Sudafrica 22
FR - Francia 21
JP - Giappone 18
BD - Bangladesh 17
ES - Italia 16
PY - Paraguay 13
CL - Cile 9
CO - Colombia 9
RU - Federazione Russa 9
SE - Svezia 8
CH - Svizzera 6
VE - Venezuela 6
MA - Marocco 5
PE - Perù 5
ET - Etiopia 4
LB - Libano 4
PK - Pakistan 4
SA - Arabia Saudita 4
UY - Uruguay 4
AT - Austria 3
BE - Belgio 3
BG - Bulgaria 3
BY - Bielorussia 3
DZ - Algeria 3
EG - Egitto 3
IQ - Iraq 3
IR - Iran 3
KR - Corea 3
KZ - Kazakistan 3
LU - Lussemburgo 3
MY - Malesia 3
PH - Filippine 3
UZ - Uzbekistan 3
AE - Emirati Arabi Uniti 2
AZ - Azerbaigian 2
BA - Bosnia-Erzegovina 2
BH - Bahrain 2
BO - Bolivia 2
DO - Repubblica Dominicana 2
IL - Israele 2
IS - Islanda 2
JM - Giamaica 2
JO - Giordania 2
LT - Lituania 2
PA - Panama 2
SY - Repubblica araba siriana 2
TH - Thailandia 2
TL - Timor Orientale 2
AM - Armenia 1
AO - Angola 1
BJ - Benin 1
BW - Botswana 1
CI - Costa d'Avorio 1
CY - Cipro 1
DK - Danimarca 1
GH - Ghana 1
GN - Guinea 1
HN - Honduras 1
HT - Haiti 1
HU - Ungheria 1
IE - Irlanda 1
KE - Kenya 1
KH - Cambogia 1
KI - Kiribati 1
LA - Repubblica Popolare Democratica del Laos 1
MD - Moldavia 1
ME - Montenegro 1
ML - Mali 1
MU - Mauritius 1
NP - Nepal 1
OM - Oman 1
PR - Porto Rico 1
PS - Palestinian Territory 1
RO - Romania 1
RS - Serbia 1
SK - Slovacchia (Repubblica Slovacca) 1
SL - Sierra Leone 1
SV - El Salvador 1
Totale 12.026
Salva come PNG Salva come JPEG
Città #
Hong Kong 672
Singapore 590
Hefei 391
Ashburn 383
Boardman 216
Beijing 182
Dallas 178
London 155
Shanghai 134
Ho Chi Minh City 84
Rome 76
Munich 62
Los Angeles 61
Council Bluffs 60
San Francisco 46
Hanoi 41
São Paulo 40
Seattle 31
Brno 28
Santa Clara 27
Turku 27
New York 26
Pune 26
West Jordan 22
Warsaw 21
Amsterdam 20
Guangzhou 20
Toronto 20
Tokyo 17
Washington 17
Mexico City 16
Rio de Janeiro 16
Helsinki 15
Montreal 15
Boston 14
Da Nang 13
Guayaquil 13
Canberra 12
Haiphong 12
Sona 11
Johannesburg 10
Chennai 9
Brasília 8
Brooklyn 8
Stockholm 8
Atlanta 7
Chicago 7
Hải Dương 7
Manchester 7
Melbourne 7
Paris 7
Shenzhen 7
Charlotte 6
Quito 6
Redmond 6
Thái Bình 6
Thái Nguyên 6
Biên Hòa 5
Curitiba 5
Milan 5
Secaucus 5
Sydney 5
Zhengzhou 5
Ankara 4
Belo Horizonte 4
Buenos Aires 4
Can Tho 4
Central 4
Frankfurt am Main 4
Kyiv 4
Lima 4
Montes Claros 4
Naples 4
Oklahoma City 4
Phoenix 4
Shijiazhuang 4
The Dalles 4
Addis Ababa 3
Asunción 3
Bari 3
Belém 3
Bogotá 3
Bologna 3
Boydton 3
Brownsville 3
Buffalo 3
Bắc Giang 3
Cachoeirinha 3
Camden 3
Campinas 3
Carapicuíba 3
Delhi 3
Florianópolis 3
Guarulhos 3
Haikou 3
Hangzhou 3
Houston 3
Jackson 3
Jakarta 3
Kuala Lumpur 3
Totale 4.087
Salva come PNG Salva come JPEG
Nome #
Altered metal metabolism in patients with HCV-related cirrhosis and hepatic encephalopathy 226
Advances in management of periprosthetic joint infections: an historical prospective study 211
A case of Henoch-Schönlein purpura in the elderly: not just a 'second childhood' 210
A mocking finding: portal cavernoma mimicking neoplastic mass. First sign of myeloproliferative disorder in a patient with Janus kinase2 V617F mutation 208
Breath-print analysis by e-nose may refine risk stratification for adverse outcomes in cirrhotic patients 205
Angiogenic cytokines in patients undergoing antiviral treatment for chronic hepatitis C virus infection 204
Deep vein thrombosis, inferior vena cava interruption and multiple thrombophilic gene mutations 201
METAL HOMEOSTASIS IN PATIENTS WITH PORTO-SYSTEMIC ENCEPHALOPATHY 200
Anti-tumor necrosis factor-alpha reverts growth hormone resistance associated with inflammatory bowel disease 199
Iloprost: an adjunctive approach to chronic viral hepatitis treatment 197
Hepatic expression of lysosomal acid lipase is reduced in non-alcoholic fatty liver disease and inversely associated with the degree of microvescicular steatosis, impairment of the autophagic process and NAFLD activity score 195
Hepatic Lysosomal Acid Lipase and lipophagy in the progression of NAFLD 193
Factors enhancing treatment of hepatitis C virus⇓infected italian people who use drugs: The CLEO-GRECAS experience 192
Breath-print analysis by e-nose for classifying and monitoring chronic liver disease: a proof-of-concept study 192
Retroperitoneal fibrosis and ankylosing spondylitis: which links? 191
Adherence to antibiotic treatment guidelines and outcomes in the hospitalized elderly with different types of pneumonia 191
Impairment of GH/IGF-1 Axis in the liver of patients with hcv-related chronic hepatitis 191
Distortion-product otoacoustic emissions: a useful test for monitoring ototoxicity induced by pegylated interferon and ribavirin treatment in patients with chronic hepatitis C 190
Choice and Outcomes of Rate Control versus Rhythm Control in Elderly Patients with Atrial Fibrillation: A Report from the REPOSI Study 186
BREATH PRINT ANALYSIS BY E-NOSE IS ASSOCIATED WITH ADVERSE OUTCOMES OF CIRRHOTIC PATIENTS INDEPENDENTLY FROM THE OTHER PROGNOSTIC INDICES 185
The hepatic expression of lysosomal acid lipase (LAL) is reduced in NAFLD patients, and associated with features of genetically determined LAL deficiency and NAFLD activity score 184
Ombitasvir, paritaprevir, and ritonavir, with or without dasabuvir, plus ribavirin for patients with hepatitis C virus genotype 1 or 4 infection with cirrhosis (ABACUS): a prospective observational study 182
Assessment of liver function by the exhaled breath-print during chronic liver disease 182
Granulomatous thyroiditis: an unexpected finding leading to the diagnosis of sarcoidosis 180
Combined evaluation of aminotransferases improves risk stratification for overall and cause-specific mortality in older patients 180
THU-390 - Hepatic expression of lysosomal acid lipase is reduced in non-alcoholic fatty liver disease and inversely associated with the degree of microvescicular steatosis, impairment of the autophagic process and NAFLD activity score 138
Accuracy of controlled attenuation parameter for assessing liver steatosis in individuals with morbid obesity before bariatric surgery 115
GH-resistance in different stages of chronic liver disease 111
Diabetes in chronic liver disease: from old concepts to new evidence 108
Exhaled breath analysis in hepatology: State-of-the-art and perspectives 106
Growth hormone-stimulated insulin-like factor-1 and acid labile subunit in chronic liver disease 102
[A 73-year-old woman with vomiting and metabolic alkalosis] 102
Coexistence of HBsAg and HBsAb in a difficult-to-treat chronic hepatitis B: loss of HBsAg with entecavir plus tenofovir combination 101
Liver cirrhosis after prolonged therapy with IFN-alpha plus interleukin-2 in a metastatic renal cancer long-term survivor 99
Association between non-invasive liver fibrosis scores and occurrence of health adverse outcomes in older people 98
METAL METABOLISM IMPAIRMENT IN PATIENTS WITH HEPATIC ENCEPHALOPATHY 96
A challenging alfa-fetoprotein in a cirrhotic patient 93
The PNPLA3 rs738409 variant can increase the risk of liver toxicity in multiple sclerosis patients treated with beta-interferon 93
Liver involvement in the course of thymoma-associated multiorgan autoimmunity: The first histological description 93
[A 61-year-old woman with abdominal pain and urination disorders] 91
Cardiotrophin-1 is not associated with carotid or coronary disease and is inversely associated with obesity in patients undergoing coronary angiography 91
Association between clinical scores of liver fibrosis and adverse non-hepatic outcomes: The key in the holistic vision of the patient 91
Diagnostic value of Virtual Touch Quantification (VTQ®) for differentiation of hemangiomas from malignant focal liver lesions 88
Determinants of alanine aminotransferase levels in a large population from Southern Italy: relationship between alanine aminotransferase and age 87
A Genetic and Metabolic Staging System for Predicting the Outcome of Nonalcoholic Fatty Liver Disease 86
Portal diameter in the diagnosis of esophageal varices in 266 cirrhotic patients: which role? 85
[Ramipril and new therapeutic possibilities for ACE-inhibitors] 84
Donna di 35 anni con febbre, dispnea e dolore alla coscia sinistra [A 35-year-old woman with fever, dyspnea, and pain in the left thigh]. 84
Current Treatment Options for HCC: From Pharmacokinetics to Efficacy and Adverse Events in Liver Cirrhosis 82
Association between non-alcoholic fatty liver disease and cardiovascular disease: a first message should pass 82
LIVER TOXICITY IN COLORECTAL CANCER PATIENTS TREATED WITH FIRST LINE FOLFIRI-CONTAINING REGIMEN: A SINGLE INSTITUTION EXPERIENCE 81
Development and Validation of a Score for Fibrotic Nonalcoholic Steatohepatitis 76
Hyperglycemia at admission, comorbidities, and in-hospital mortality in elderly patients hospitalized in internal medicine wards: data from the RePoSI Registry 75
Biopsy in chronic liver disease: proposal for a shared path between clinicians and pathologists 75
AISF update on the diagnosis and management of adult-onset lysosomal storage diseases with hepatic involvement 72
A Polygenic Risk Score to Refine Risk Stratification and Prediction for Severe Liver Disease by Clinical Fibrosis Scores 72
An overview of deregulated lipid metabolism in nonalcoholic fatty liver disease with special focus on lysosomal acid lipase 70
Brain and kidney, victims of atrial microembolism in elderly hospitalized patients? Data from the REPOSI study 67
Pattern of comorbidities and 1-year mortality in elderly patients with COPD hospitalized in internal medicine wards: data from the RePoSI Registry 65
Combining genetic variants to improve risk prediction for nafld and its progression to cirrhosis: a proof of concept study 60
Prognostication in NAFLD: physiological bases, clinical indicators, and newer biomarkers 54
Metabolic and genetic determinants for progression to severe liver disease in subjects with obesity from the UK Biobank 51
Sarcopenia in Hepatocellular Carcinoma: Pathogenesis and Management 50
Pain and Frailty in Hospitalized Older Adults 49
The role of S-adenosyl methionine in preventing FOLFOX-induced liver toxicity: a retrospective analysis in patients affected by resected colorectal cancer treated with adjuvant FOLFOX regimen 47
Liver toxicity in colorectal cancer patients treated with first-line FOLFIRI-containing regimen: a single institution experience 47
Reelin expression in human liver of patients with chronic hepatitis C infection 46
Lipophagy Impairment Is Associated With Disease Progression in NAFLD 46
Identification of matrix metalloprotease 10 (mmp10) as a key new mediator of the regenerative response of the liver 45
Portal inflammation during NAFLD is frequent and associated with the early phases of putative hepatic progenitor cell activation 44
Relationship between adipose tissue dysfunction, vitamin D deficiency and the pathogenesis of non-alcoholic fatty liver disease 43
Reply to the Letter: “Low levels of transaminase and mortality risk in older people with special reference to sarcopenia” 43
Incidence and Outcome of Pneumomediastinum in Non-ICU Hospitalized COVID-19 Patients 42
TNF-alpha and growth hormone resistance in patients with chronic liver disease 41
Identification of fibroblast growth factor 15 as a novel mediator of liver regeneration and its application in the prevention of post-resection liver failure in mice 40
Identification of Fibroblast growth factor 15 as a novel mediator of liver regeneration and its application in the prevention of post-resection liver failure 40
What changed in the Italian internal medicine and geriatric wards during the lockdown 40
Matrix metalloproteinase 10 contributes to hepatocarcinogenesis in a novel crosstalk with the stromal derived factor 1/C-X-C chemokine receptor 4 axis 39
Ileal FGF15 contributes to fibrosis-associated hepatocellular carcinoma development 38
Hepatic matrix metalloproteinase-10 exerts a hepatoprotective role after acute liver inury 38
Portal and interface chronic inflammation are associated with the progenitor cell compartment activation during NAFLD 38
Lysosomal acid lipase activity is reduced both in cryptogenic cirrhosis and in cirrhosis of known etiology 37
Matrix metalloproteinase-10 contributes to hepatocellular carcinoma development in a novel crosstalk with stromal derived growth factor 1/C-X-C chemokine receptor 4 axis 37
Interplay between SIRT-3, metabolism and its tumor suppressor role in hepatocellular carcinoma 37
Real-world experience with obeticholic acid in patients with primary biliary cholangitis 37
Predictors of serious adverse events and non-response in cirrhotic patients with primary biliary cholangitis treated with obeticholic acid 36
The Role of Ribavirin in the Combination Therapy of Hepatitis C Virus Infection 36
Hepatic toll-like receptor 4 expression is associated with portal inflammation and fibrosis in patients with NAFLD 36
Hepatitis C virus-related B cell subtypes in non Hodgkin's lymphoma 36
Multimorbidity and polypharmacy in the elderly: lessons from REPOSI 36
MMP10 EXPRESSION PROTECTS FROM ACUTE LIVER INJURY BUT CONTRIBUTES TO HEPATOCELLULAR CARCINOMA PROGRESSION 36
Hepatic matrix metalloproteinase-10 exerts a hepatoprotective role after acute liver injury 36
Partitioned polygenic risk scores identify distinct types of metabolic dysfunction-associated steatotic liver disease 35
Hepatocellular carcinoma in alcoholic liver disease: current management and recent advances 35
Reelin expression in liver and pancreas and its correlation with liver fibrosis 35
The role of S-adenosylmethionine in preventing oxaliplatin-induced liver toxicity: a retrospective analysis in metastatic colorectal cancer patients treated with bevacizumab plus oxaliplatin-based regimen 35
Lack of reduction of serum alphafetoprotein during treatment with direct antiviral agents predicts hepatocellular carcinoma development in a large cohort of patients with HCV-related cirrhosis 35
Need for Deprescribing in Hospital Elderly Patients Discharged with a Limited Life Expectancy: The REPOSI Study 35
Liver vitamin D receptor, CYP2R1 and CYP27A1 expression related to progression of metabolic and viral liver damage 35
Machine learning in primary biliary cholangitis: A novel approach for risk stratification 35
Totale 9.595
Salva come PNG Salva come JPEG
Categoria #
all - tutte 90.141
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 90.141
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022336 0 2 8 0 3 3 2 6 46 4 4 258
2022/2023112 12 1 6 4 10 2 30 4 3 5 33 2
2023/2024636 26 50 18 62 61 269 2 37 8 40 20 43
2024/20258.381 131 57 236 45 110 186 143 34 482 562 3.017 3.378
2025/20262.639 620 332 457 810 255 165 0 0 0 0 0 0
Totale 12.104